[DT‐02–02]: IDALOPIRDINE, A 5‐HT6 ANTAGONIST, AS ADJUNCTIVE THERAPY TO ACETYLCHOLINESTERASE INHIBITORS IN PATIENTS WITH MILD‐MODERATE ALZHEIMER's DISEASE: KEY OUTCOMES FROM THE STAR PHASE III PROGRAM. (1st July 2017) - Atri, Alireza; Frölich, Lutz; Ballard, Clive; Tariot, Pierre; Molinuevo, José Luis; Boneva, Neli; Windfeld, Kristian; Cummings, Jeffrey L.